Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 75: 246-255, 1993;
8750-7587/93 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorion, D.
Right arrow Articles by Pang, C. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorion, D.
Right arrow Articles by Pang, C. Y.

Journal of Applied Physiology, Vol 75, Issue 1 246-255, Copyright © 1993 by American Physiological Society


ARTICLES

Role of xanthine oxidase in reperfusion injury of ischemic skeletal muscles in the pig and human

D. Dorion, A. Zhong, C. Chiu, C. R. Forrest, B. Boyd and C. Y. Pang
Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.

We investigated whether xanthine oxidase (XO) is a major source of oxygen-derived free radicals (oxy-radicals) in the pig and human skeletal muscles. It was observed that xanthine dehydrogenase and XO activities in nonischemic pig latissimus dorsi (LD) and gracilis muscles and human LD and rectus abdominis (RA) muscles were < 0.5 mU/g wet wt. The pig LD muscle hypoxanthine content increased significantly from 0.33 +/- 0.02 to 2.33 +/- 0.44 mumol/g dry wt after 5 h of warm ischemia, but the muscle uric acid content remained unchanged up to 2 h of reperfusion. Similarly, the hypoxanthine content in the human LD and RA muscles increased from 0.33 +/- 0.03 to 0.84 +/- 0.23 mumol/g dry wt after 2.0-3.5 h of warm ischemia, and the muscle uric acid content remained unchanged at the end of 15-90 min of reperfusion. Furthermore, 5 days of allopurinol treatment (25 mg/kg iv twice daily) starting 2 days before ischemia or 3 days of oxypurinol treatment (25 mg/kg iv twice daily) starting 15 min before reperfusion did not attenuate the extent of skeletal muscle necrosis in pig LD muscles subjected to 5 h of ischemia and 48 h of reperfusion. However, deferoxamine treatment (250 mg/kg iv twice daily) starting before or after ischemia, as described above, significantly reduced the extent of pig LD muscle necrosis. Finally, at 2 and 48 h of reperfusion significantly higher muscle neutrophil contents were seen in ischemic than in nonischemic control pig LD muscles. Neutrophil depletion with mechlorethamine (0.75 mg/kg iv) significantly reduced the extent of necrosis in pig LD muscles. These observations indicate that XO is not a major source of oxy-radicals in ischemia/reperfusion injury in the pig gracilis and LD muscles and human RA and LD muscles.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. E. McAllister, H. Ashrafpour, N. Cahoon, N. Huang, M. A. Moses, P. C. Neligan, C. R. Forrest, J. E. Lipa, and C. Y. Pang
Postconditioning for salvage of ischemic skeletal muscle from reperfusion injury: efficacy and mechanism
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R681 - R689.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Pacher, A. Nivorozhkin, and C. Szabo
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.
Pharmacol. Rev., March 1, 2006; 58(1): 87 - 114.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. A. Moses, P. D. Addison, P. C. Neligan, H. Ashrafpour, N. Huang, S. E. McAllister, J. E. Lipa, C. R. Forrest, and C. Y. Pang
Inducing late phase of infarct protection in skeletal muscle by remote preconditioning: efficacy and mechanism
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1609 - R1617.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. A. STOFAN, L. A. CALLAHAN, A. F. DiMARCO, D. E. NETHERY, and G. S. SUPINSKI
Modulation of Release of Reactive Oxygen Species by the Contracting Diaphragm
Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 891 - 898.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Kadambi and T. C. Skalak
Role of leukocytes and tissue-derived oxidants in short-term skeletal muscle ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H435 - H443.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
T. L. Clanton, L. Zuo, and P. Klawitter
Oxidants and Skeletal Muscle Function: Physiologic and Pathophysiologic Implications
Experimental Biology and Medicine, December 1, 1999; 222(3): 253 - 262.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
G. Supinski, D. Nethery, D. Stofan, L. Szweda, and A. DiMarco
Oxypurinol administration fails to prevent free radical-mediated lipid peroxidation during loaded breathing
J Appl Physiol, September 1, 1999; 87(3): 1123 - 1131.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online